{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T20:11:16Z","timestamp":1788898276020,"version":"build-2803163510"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100008272","name":"Novartis Pharmaceuticals Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.ahj.2024.10.009","type":"journal-article","created":{"date-parts":[[2024,10,16]],"date-time":"2024-10-16T23:46:53Z","timestamp":1729122413000},"page":"50-58","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Real-world exploration of LDL-cholesterol management in patients with atherosclerotic cardiovascular disease"],"prefix":"10.1016","volume":"279","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2666-7132","authenticated-orcid":false,"given":"Nishant P.","family":"Shah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hillary","family":"Mulder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Lydon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Chiswell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingdi","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zachary","family":"Lampron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manesh R.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Taubes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenliang","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suresh R.","family":"Mulukutla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anum","family":"Saeed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel P.","family":"Morin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven M.","family":"Bradley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian F.","family":"Hernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neha J.","family":"Pagidipati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ahj.2024.10.009_bib0001","first-page":"e1046","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: executive summary: a report of the American college of cardiology\/American heart association task force on clinical practice guidelines","volume":"139","author":"Grundy","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2024.10.009_bib0002","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","article-title":"2019 ESC\/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk","volume":"41","author":"Mach","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2024.10.009_bib0003","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1016\/j.jacc.2022.07.006","article-title":"2022 ACC expert consensus decision pathway on the role of nonstatin therapies for LDL-cholesterol lowering in the management of atherosclerotic cardiovascular disease risk: a report of the American college of cardiology solution set oversight committee","volume":"80","author":"Lloyd-Jones","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2024.10.009_bib0004","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.011246","article-title":"PCSK9 Inhibitor use in the real world: data from the national patient-centered research network","volume":"8","author":"Chamberlain","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.ahj.2024.10.009_bib0005","doi-asserted-by":"crossref","first-page":"3187","DOI":"10.3390\/jcm12093187","article-title":"Real-world attainment of low-density lipoprotein cholesterol goals in patients at high risk of cardiovascular disease treated with high-intensity statins: the Teresa study","volume":"12","author":"Barrios","year":"2023","journal-title":"J Clin Med"},{"key":"10.1016\/j.ahj.2024.10.009_bib0006","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1016\/j.jacc.2022.02.048","article-title":"High-intensity statin use among patients with atherosclerosis in the U.S","volume":"79","author":"Nelson","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2024.10.009_bib0007","doi-asserted-by":"crossref","first-page":"6825","DOI":"10.3390\/jcm11226825","article-title":"Cardiovascular risk profile and lipid management in the population-based cohort study Latino: 20 years of real-world data","volume":"11","author":"Gavina","year":"2022","journal-title":"J Clin Med"},{"key":"10.1016\/j.ahj.2024.10.009_bib0008","doi-asserted-by":"crossref","first-page":"675","DOI":"10.46747\/cfp.6910675","article-title":"PEER simplified lipid guideline 2023 update","volume":"69","author":"Kolber","year":"2023","journal-title":"Can Fam Physician"},{"key":"10.1016\/j.ahj.2024.10.009_bib0009","article-title":"A systematic review of lipid management in secondary prevention and comparison of international lipid management pathways","volume":"15","author":"Khan","year":"2023","journal-title":"Cureus"},{"issue":"8","key":"10.1016\/j.ahj.2024.10.009_bib0010","doi-asserted-by":"crossref","first-page":"e347","DOI":"10.1161\/CIR.0000000000001209","article-title":"American heart association council on epidemiology and prevention statistics committee and stroke statistics subcommittee. 2024 heart disease and stroke statistics: a report of us and global data from the American heart association","volume":"149","author":"Martin","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2024.10.009_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajpc.2020.100010","article-title":"Lipid treatment and goal attainment characteristics among persons with atherosclerotic cardiovascular disease in the United States","volume":"1","author":"Klimchak","year":"2020","journal-title":"Am J Prev Cardiol"},{"key":"10.1016\/j.ahj.2024.10.009_bib0012","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.jacl.2016.06.011","article-title":"Prevalence of the American College of Cardiology\/American Heart Association statin eligibility groups, statin use, and low-density lipoprotein cholesterol control in US adults using the National Health and Nutrition Examination Survey 2011\u20132012","volume":"10","author":"Wong","year":"2016","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.ahj.2024.10.009_bib0013","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1001\/jamacardio.2021.1810","article-title":"Use of Lipid-lowering therapies over 2 years in Gould, a registry of patients with atherosclerotic cardiovascular disease in the US","volume":"6","author":"Cannon","year":"2021","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.ahj.2024.10.009_bib0014","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.amjcard.2022.10.033","article-title":"Bending the cardiovascular event curve by evaluating the potential impact of achieving low-density lipoprotein cholesterol goal across a large health system among secondary prevention patients","volume":"186","author":"Shah","year":"2023","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ahj.2024.10.009_bib0015","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1089\/jwh.2015.5282","article-title":"Gender disparities in lipid-lowering therapy in cardiovascular disease: insights from a managed care population","volume":"25","author":"Rodriguez","year":"2016","journal-title":"J Women's Heal"},{"key":"10.1016\/j.ahj.2024.10.009_bib0016","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jacl.2022.11.009","article-title":"Sex-related differences in premature cardiovascular disease in familial hypercholesterolemia","volume":"17","author":"Agarwala","year":"2023","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.ahj.2024.10.009_bib0017","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2022\/7537510","article-title":"Low-density lipoprotein cholesterol levels in coronary artery disease patients: opportunities for improvement. Severino p, ed","volume":"2022","author":"Martin","year":"2022","journal-title":"Cardiol Res Pract"},{"key":"10.1016\/j.ahj.2024.10.009_bib0018","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.45964","article-title":"National trends in racial and ethnic disparities in use of recommended therapies in adults with atherosclerotic cardiovascular disease, 1999-2020","volume":"6","author":"Lu","year":"2023","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.ahj.2024.10.009_bib0019","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/S0140-6736(16)32380-7","article-title":"Socioeconomic status and the 25 \u00d7 25 risk factors as determinants of premature mortality: a multicohort study and meta-analysis of 1\u00b77 million men and women","volume":"389","author":"Stringhini","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2024.10.009_bib0020","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2018.4240","article-title":"Racial disparities in patient characteristics and survival after acute myocardial infarction","volume":"1","author":"Graham","year":"2018","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.ahj.2024.10.009_bib0021","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1161\/JAHA.114.001197","article-title":"National trends in recurrent ami hospitalizations 1 year after acute myocardial infarction in medicare beneficiaries","volume":"3","author":"Chaudhry","year":"2014","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.ahj.2024.10.009_bib0022","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1161\/CIRCOUTCOMES.122.009787","article-title":"Gaps in guideline-based lipid-lowering therapy for secondary prevention in the United States: a retrospective cohort study of 322 153 patients","volume":"16","author":"Navar","year":"2023","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.ahj.2024.10.009_bib0023","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1080\/00325481.2022.2117498","article-title":"LDL-C target attainment in secondary prevention of ASCVD in the United States: barriers, consequences of nonachievement, and strategies to reach goals","volume":"134","author":"Underberg","year":"2022","journal-title":"Postgrad Med"},{"key":"10.1016\/j.ahj.2024.10.009_bib0024","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/clc.22713","article-title":"PCSK9 inhibitor access barriers\u2014issues and recommendations: improving the access process for patients, clinicians and payers","volume":"40","author":"Baum","year":"2017","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.ahj.2024.10.009_bib0025","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1001\/jamacardio.2017.3451","article-title":"Association of prior authorization and out-of-pocket costs with patient access to PCSK9 inhibitor therapy","volume":"2","author":"Navar","year":"2017","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.ahj.2024.10.009_bib0026","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1016\/S0735-1097(24)03680-5","article-title":"The impact of lipoprotein(a) testing in patients with atherosclerotic cardiovascular disease in a large healthcare system in the Us","volume":"83","author":"Dai","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2024.10.009_bib0027","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1001\/jamacardio.2022.4018","article-title":"Results of a remotely delivered hypertension and lipid program in more than 10 000 patients across a diverse health care network","volume":"8","author":"Blood","year":"2023","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.ahj.2024.10.009_bib0028","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s12325-023-02716-6","article-title":"LOGAN-CV: a prospective study of a multifaceted intervention targeting united states clinicians to improve guideline-based management of lipid-lowering therapy","volume":"41","author":"McKoy","year":"2024","journal-title":"Adv Ther"},{"key":"10.1016\/j.ahj.2024.10.009_bib0029","unstructured":"American College of Cardiology Program to Increase Cholesterol Screenings. Published 2023. Accessed June 2, 2024. https:\/\/www.acc.org\/About-ACC\/Press-Releases\/2023\/09\/12\/13\/00\/ACC-Program-to-Increase-Cholesterol-Screenings"},{"key":"10.1016\/j.ahj.2024.10.009_bib0030","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1001\/jama.2023.2854","article-title":"Coordinated care to optimize cardiovascular preventive therapies in type 2 diabetes","volume":"329","author":"Pagidipati","year":"2023","journal-title":"JAMA"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870324002710?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870324002710?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,2]],"date-time":"2024-12-02T09:05:16Z","timestamp":1733130316000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870324002710"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":30,"alternative-id":["S0002870324002710"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2024.10.009","relation":{},"ISSN":["0002-8703"],"issn-type":[{"value":"0002-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Real-world exploration of LDL-cholesterol management in patients with atherosclerotic cardiovascular disease","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2024.10.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}